文献速递药物相互作用

氯吡格雷与质子泵抑制剂联用处方行为回顾性分析

Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour.
PubMed 文献 · Br J Clin Pharmacol · 2025-01-31

该研究回顾性分析2015至2022年荷兰门诊处方记录,覆盖约62%门诊处方,发现氯吡格雷联合奥美拉唑或埃索美拉唑(不良组合)比例从19.7%降至8.7%,但仍常被开具,更常见于内科医生、女性及多重用药患者,需加强教育。

要点

  • 氯吡格雷与奥美拉唑/埃索美拉唑联用比例2015-2022年从19.7%降至8.7%。
  • 不良组合更常由内科医生开具,多见于女性和多重用药(>10种药)患者。
  • 尽管下降,该不良组合在荷兰仍常被处方,需对药师和处方者教育。

核心结论

  • 2015至2022年荷兰门诊中氯吡格雷联合奥美拉唑或埃索美拉唑的比例从19.7%降至8.7%,但该不良组合仍常被处方。

研究设计与样本

  • 回顾性分析2015至2022年荷兰门诊药物处方记录,数据库覆盖约62%的荷兰门诊处方。

主要发现

  • 使用奥美拉唑或埃索美拉唑作为胃保护药与氯吡格雷联用的患者比例从2015年的19.7%降至2022年的8.7%。
  • 该不良药物组合更常由内科医生开具,更常见于女性及多重用药(使用>10种药物)患者。

临床怎么用

  • 临床应避免氯吡格雷与奥美拉唑或埃索美拉唑联用,选择药代动力学替代胃保护药。
  • 对药师和处方者开展该药物相互作用教育,以减少不良组合处方。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Since omeprazole and esomeprazole reduce the effect of clopidogrel on the inhibition of platelet aggregation, concomitant use of these drugs has been discouraged by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) since 2010. Currently, it is unknown how often this undesired drug-drug combination is prescribed. The aim of this article is to determine the proportion of patients using omeprazole or esomeprazole among patients using clopidogrel with gastroprotective drugs and to identify differences between these two groups with regard to patient characteristics and prescriber characteristics. METHODS: This was a retrospective analysis of Dutch outpatient medication prescription records between 2015 and 2022. The database had a coverage of approximately 62% of all outpatient prescriptions dispensed in The Netherlands. RESULTS: The proportion of patients using omeprazole or esomeprazole as gastroprotective drug in combination with clopidogrel declined from 19.7% to 8.7% between 2015 and 2022. The undesired drug-drug combination was more often prescribed by internists, to women and to patients with polypharmacy (using >10 drugs). CONCLUSIONS: Although the proportion of patients using clopidogrel together with omeprazole or esomeprazole declined between 2015 and 2022, the undesired combination is still frequently prescribed in The Netherlands. Education about this drug-drug interaction for pharmacists and prescribers is needed since pharmacotherapeutic alternatives are available.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wilkes S, van de Wiel K, Mulder K, et al. Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour. Br J Clin Pharmacol. 2025. PMID: 39891382. doi:10.1111/bcp.16402

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。